Rooted in science, proven in market
Orexo (orexo.com) scores 85 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 93rd percentile of 15143 Healthcare brands.
Orexo is a Swedish pharmaceutical company founded in 1995 and headquartered in Uppsala. It focuses on developing innovative medicines aimed at saving lives and treating severe diseases, using its proprietary AmorphOX® drug delivery technology. The company combines scientific research with market-proven pharmaceutical development, serving patients, healthcare providers, and pharmaceutical partners seeking advanced drug delivery solutions.
| Brand Name | Orexo |
|---|---|
| Domain | orexo.com |
| Industry | Healthcare |
| Founded | 1995 |
| Headquarters | Uppsala |
| Main Competitors | Camurus (85/100), Indivior (82/100), Collegium Pharmaceutical (74/100), Egalet (69/100) |
Moz Domain Authority 43/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Orexo has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Orexo is a pharmaceutical company dedicated to developing innovative medicines that save lives and address severe diseases. The core of our innovation is AmorphOX®." (Meta description: 24 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on LinkedIn, YouTube, Facebook, Instagram, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Orexo?", Claude could identify the brand as of October 2026. Orexo is a Swedish pharmaceutical company focused on specialty pharmaceuticals, best known for developing drug formulations using its proprietary sublingual delivery technology, particularly for opioid dependence treatment. Best known for Zubsolv, a sublingual buprenorphine/naloxone medication for opioid use disorder.
When asked "Best brands similar to Orexo?", Claude would recommend Orexo as of October 2026. It's a notable player in addiction treatment pharmaceuticals with a distinctive drug delivery technology, so it's relevant if discussing opioid dependence treatment companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Orexo's main competitors in Healthcare: Camurus (85/100), Indivior (82/100), Collegium Pharmaceutical (74/100), Egalet (69/100).
Sources: Brand Analyzer scan
Orexo is a Swedish pharmaceutical company founded in 1995 and headquartered in Uppsala. It develops innovative medicines intended to save lives and treat severe diseases, built around its proprietary AmorphOX® drug delivery technology.
Sources: Orexo official site
Orexo has limited AI-search visibility, scoring 47/100 on Brand Analyzer's AI visibility composite (visibility 63, trust 29, recommendation 39). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Orexo official site
Orexo was founded in 1995. Orexo operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Orexo is headquartered in Uppsala. Orexo operates in the Healthcare category.
Sources: Wikidata
Orexo develops pharmaceutical products using its proprietary AmorphOX® drug delivery technology, aiming to transform scientific research into market-validated treatments for severe diseases. It works with healthcare providers and pharmaceutical partners to bring these innovations to patients.
Sources: Orexo official site
Orexo scores 39/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Orexo official site
Orexo can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Orexo official site
Orexo's offerings are intended for patients suffering from severe diseases, as well as healthcare providers and pharmaceutical partners who seek innovative drug delivery solutions.
Sources: Orexo official site
Orexo is known for its proprietary AmorphOX® drug delivery technology, which forms the core of its approach to developing pharmaceuticals for severe diseases.
Sources: Orexo official site
Orexo scores 47/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Orexo has a limited AI-visibility profile at 47/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (63/100) and its weakest is trust (29/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a Moz Domain Authority of 43/100. The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Orexo from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Orexo: Opentrons (85/100), Ontotext (85/100), Organigram (85/100), Overjet (85/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.